Michael P. Bailey - 20 Dec 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Reporting relationship: President & CEO, Director
Issuer ticker: N/A
Reported as of: 20 Dec 2022
Net transaction value: +$1,248,144
SEC form: 4
Accepted by SEC: 22 Dec 2022, 15:46:26 UTC
Prior SEC filing: 17 Feb 2022
Next SEC filing: 19 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Danielle V. Holland, attorney in fact

Key filing fact

Michael P. Bailey filed Form 4 for AVEO PHARMACEUTICALS, INC. on 22 Dec 2022.

Key facts

This page summarizes Michael P. Bailey's Form 4 filing for AVEO PHARMACEUTICALS, INC..
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 22 Dec 2022, 15:46.

Change

Previous filing in this sequence was filed on 17 Feb 2022.
Current net transaction value: +$1,248,144.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVEO transaction

Common Stock

Options Exercise

Transaction value: $164,294
Shares: +26,499
Change %: +47%
Price: $6.20
Shares after: 82,920
Date: 20 Dec 2022
Ownership: Direct
Footnotes: F1

AVEO transaction

Common Stock

Options Exercise

Transaction value: $480,043
Shares: +85,722
Change %: +95%
Price: $5.60
Shares after: 175,642
Date: 20 Dec 2022
Ownership: Direct

AVEO transaction

Common Stock

Options Exercise

Transaction value: $603,807
Shares: +164,525
Change %: +94%
Price: $3.67
Shares after: 340,167
Date: 20 Dec 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVEO transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -26,499
Change %: -22%
Price: $0.000000
Shares after: 93,500
Date: 20 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,499
Exercise price: $6.20
Footnotes: F2

AVEO transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -85,722
Change %: -71%
Price: $0.000000
Shares after: 35,302
Date: 20 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85,722
Exercise price: $5.60
Footnotes: F3

AVEO transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -164,525
Change %: -21%
Price: $0.000000
Shares after: 625,192
Date: 20 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 164,525
Exercise price: $3.67
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes 7,110 shares purchased by the Reporting Person under the Company's 2010 Employee Stock Purchase Plan, as amended.

Footnote F2

The shares underlying this option vest in equal monthly installments from February 6, 2019 through February 6, 2023, subject to the Reporting Person's continued service to the Company.

Footnote F3

The shares underlying this option vest in equal monthly installments from February 5, 2020 through February 5, 2024, subject to the Reporting Person's continued service to the Company.

Footnote F4

The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.